查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球自动输血系统市场 - 2023-2030 年
市场调查报告书
商品编码
1319141

全球自动输血系统市场 - 2023-2030 年

Global Autotransfusion System Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球自体输血系统市场规模在 2022 年达到 3.214 亿美元，预计到 2030 年将达到 4.826 亿美元，2023-2030 年的年复合增长率为 5.3%。

自体输血是指输血者接受自身血液，而非血库中的异体（分离供体）血液。自体输血的目的仍然是保持无菌环境、防止采集的血液凝固、过滤血液并输给病人。

市场动态

血管手术的增加推动了自动输血系统市场的发展

推动自体输血市场发展的主要因素是血管手术数量的增加。越来越多的人罹患血管疾病，为了避免排斥反应，人们开始使用自体输血治疗。

例如，根据《血管外科杂志》的统计，每年要进行 107 例手术。在确定的血管外科医生群体中，11%的人进行了 200 多例手术，21%的人进行了不到 50 例手术。一名血管外科医生平均每年进行 107 例血管手术。因此，血管手术数量的增加正在促进市场增长。

技术进步推动全球自体输血系统市场增长

自体输血新技术的引入和发展推动了自体输血系统市场的发展。例如，美国国立卫生研究院（NIH）在 2022 年公布的一项研究中指出，一种医疗设备旨在收集和清洗术中采集的血液，以便在整个过程结束时获得浓缩的血液制品。

该设备通过中空纤维集成了创新的过滤技术，不仅能浓缩红细胞，还能浓缩血液制品中的血小板，并清除污染物。

缺乏熟练的专业人员进行操作会阻碍市场增长

能够更好地执行自动输血系统的熟练专业人员数量较少，这将阻碍市场的增长。随着各种手术数量的增加，需要大量专业人员来治疗病人。因此，技术熟练的专业人员数量减少会降低市场增长。

COVID-19 影响分析

COVID-19 大流行对自体输血市场产生了负面影响。许多自体输血中心和诊断中心关闭，影响了大量患者，输血率也随之下降。自体输血治疗被推迟，造成了严重的健康问题。

俄乌战争影响分析

据估计，俄乌冲突对全球自体输血系统市场的影响不大，因为该地区的主要市场参与者较少。不过，在预测期内，原材料进出口的影响预计对全球自体输血系统市场的增长影响不大。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：定义和概述

第3章：执行摘要

  • 按产品类型分類的片段
  • 按最终用户划分
  • 按地区划分

第四章：动态

  • 影响因素
    • 驱动因素
      • 最大失血量手术的发生率增加
      • 无法获得献血者的情况增加
    • 限制因素
      • 自动输血系统成本高昂
    • 机会
      • 产品开发方面的技术进步
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章 ：俄乌战争影响分析

第8章：按产品类型划分

  • 术中自体输血系统
  • 术后自动输血系统
  • 双模式自体输血系统
  • 自体输血配件

第九章：按技术分类

  • 预存自体捐赠 (PAD)
  • 急性正常血容量血液稀释（ANH）
  • 围手术期细胞挽救 (PCS)

第 10 章：按应用分类

  • 骨科
  • 神经内科
  • 心脏病学
  • 其他

第 11 章：按最终用户

  • 医院
  • 专科诊所
  • 其他

第十二章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 13 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第14章：公司简介

  • Armstrong Medical.
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • Beijing ZKSK Technology
  • Medtronic
  • Haemonetics
  • LivaNova
  • BD
  • Zimmer
  • Terumo BCT
  • Atrium Medical Corporation
  • Fresenius Kabi

第 15 章 ：附录

简介目录
Product Code: MD6545

Market Overview

Global Autotransfusion System Market reached US$ 321.4 million in 2022 and is expected to reach US$ 482.6 million by 2030 growing with a CAGR of 5.3% during the forecast period 2023-2030.

Autotransfusion is a process wherein a person receives their own blood for a transfusion instead of banked allogenic (separate-donor) blood. The goal of autotransfusion remains the same, to maintain a sterile field, prevent clotting of the collected blood, filtration of the blood, and administration to the patient.

Market Dynamics

An Increase in the Incidence of Vascular Surgeries is Driving the Autotransfusion System Market

The major factor that is driving the autotransfusion market is the increase in the number of vascular surgeries. A number of people are suffering from vascular diseases, which are leading to autotransfusion treatment in order to avoid rejection.

For instance, according to the Journal of Vascular Surgery, 107 operations were performed annually. Among the defined cohort of vascular surgeons, 11% performed more than 200 procedures, and 21% performed fewer than 50. On average, 107 vascular procedures were performed annually by a vascular surgeon. Thus, increase in the number of vascular surgeries is increasing the market growth.

The rise in Technological Advancements is Demanding the Global Autotransfusion System Market Growth

The introduction of new technologies and developments in autotransfusion has been the drive for the autotransfusion system market. For instance, in 2022, NIH revealed a study stating that a medical device intended to collect and wash intra-operatively collected blood to obtain a concentrated blood product at the end of the process.

The device integrates an innovative filtration technology through hollow fibers, allowing RBCs concentration but also platelets within the concentrated blood product and contaminant elimination.Thus technological developments havebeen a drive for the autotransfusion system market.

A lack of Skilled Professionals to Perform the Procedure can Hamper the Market Growth

Less number of skilled professionals to perform the autotransfusion system better will decline the growth of the market. As there is an increase in the number of different kinds of surgeries there is a need foran ample number of professionals to treat the patients. Thus reduced count of skilled professionals can decline the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a negative impact on the autotransfusion market. Many of the autotransfusion centers and diagnostic centers were closed, which has affected a large number of patients, and the transfusion rate has declined. The autotransfusion treatments have been postponed, which has created severe health issues This resulted in a significant increase in the number of patients lacking the treatment.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global autotransfusion system market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global autotransfusion system market growth over the forecast period.

Segment Analysis

The global autotransfusion system market is segmented based on product type, techniques, application, and end user.

The Cardiology Segment Holds the Dominant Position in the Market Over Forecast Period

Cardiology holds the most significant market share of around 41.7% during the forecast period. Autotransfusion of blood aspirated from the pericardium enables the operator to maintain hemodynamic stability (until surgery can be performed) and attempt to seal the cardiac perforation despite substantial and persistent fluid accumulation.

For instance, according to Lifespan Organization, there are about 500,000 open heart surgeries performed each year. It is most often used for complicated procedures, such as coronary artery bypass, or complex procedures to the aorta or the heart itself. An increase in surgeries required autotransfusion to be raised. Thus, the above factors are influencing the growth of the segment.

Geographical Analysis

Europe accounted for 27.9% of the Market Share Owing to the Prevalence of Surgeries and Increasing Technological Advancements

Due to the increased cardiac surgeries in this region ,there is an ample need for autotransfusion to be performed. The increase in the requirement for autotransfusion has increased the development of autotransfusion systems which has influenced the growth of the autotransfusion market in these regions.

For instance, according to CDS, 38 900 heart bypasses were conducted in Germany in 2020; this was more than double the number in any of the other EU Member States (16 400 were conducted in France). Hypertension is on the rise in Europe, especially in the rural and urban populations, which is increasing the incidence of cardiac surgeries.

Competitive Landscape

The major global players in the autotransfusion market include: BD, Fresenius Kabi, Zimmer, Armstrong Medical, Beijing ZKSK Technolgy, Haemonetics, LivaNova, Terumo BCT, Atrium Medical Corporation, Medtronic among others.

Why Purchase the Report?

  • To visualize the global autotransfusion system market segmentation based on product type, techniques, application, and end-user, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global autotransfusion system market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global autotransfusion system market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by End User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in incidence of surgeries with maximum blood loss
      • 4.1.1.2. Increase in the unavailability of the donors
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of an autotransfusion system
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements in product development
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Impact Analysis

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Intraoperative Autotransfusion Systems*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Postoperative Autotransfusion Systems
  • 8.4. Dual-Mode Autotransfusion Systems
  • 8.5. Autotransfusion Accessories

9. By Techniques

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Techniques
    • 9.1.2. Market Attractiveness Index, By Techniques
  • 9.2. Predeposit autologous donation (PAD) *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Acute normovolaemic haemodilution (ANH)
  • 9.4. Perioperative cell salvage (PCS)

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Orthopedic*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Neurology
  • 10.4. Cardiology
  • 10.5. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Specialty Clinics
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.7.1. U.S.
      • 12.2.7.2. Canada
      • 12.2.7.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.7.1. Germany
      • 12.3.7.2. U.K.
      • 12.3.7.3. France
      • 12.3.7.4. Spain
      • 12.3.7.5. Italy
      • 12.3.7.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.7.1. Brazil
      • 12.4.7.2. Argentina
      • 12.4.7.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.7.1. China
      • 12.5.7.2. India
      • 12.5.7.3. Japan
      • 12.5.7.4. Australia
      • 12.5.7.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Armstrong Medical.
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Beijing ZKSK Technology
  • 14.3. Medtronic
  • 14.4. Haemonetics
  • 14.5. LivaNova
  • 14.6. BD
  • 14.7. Zimmer
  • 14.8. Terumo BCT
  • 14.9. Atrium Medical Corporation
  • 14.10. Fresenius Kabi

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us